BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Trinean nv to In-License PerkinElmer, Inc. (PKI) Technology


2/4/2013 2:32:31 PM

Ghent, Belgium – February 4th, 2013 - Trinean, the leading provider of microfluidic spectrophotometry platforms, today announced that it has entered into a license agreement with PerkinElmer to license certain microfluidics technology owned by its subsidiary, Caliper Life Sciences, Inc., in the field of UV-VIS quantification analysis.

Under the agreement, Trinean obtained a license for the design and development of microfluidic cartridges and instruments in the field of UV/VIS quantification of light- absorbing substances for certain life sciences research applications.

“We are very pleased with this agreement between PerkinElmer and Trinean. The combined IP from Trinean and PerkinElmer will boost the expansion of our platform for DNA, RNA and protein quantification and quality control," said Philippe Stas, CEO of Trinean. "Our microfluidic chips generate high quality UV/Vis spectral absorbance profiles of bio-molecules. They are designed to meet the requirements of labs requiring speed and minimal sample usage. Our unmatched large measurement range allows quantification of undiluted protein samples in real-time thereby significantly shortening the purification process.”

"The use of microfluidics for UV/Vis spectrometry is an exciting market development," said Kevin Hrusovsky, Life Sciences President, PerkinElmer. "We continue to leverage our microfluidics portfolio through licensing collaborations such as our agreement with Trinean to extend our market reach and create additional revenue opportunities."

More information about PerkinElmer’s microfluidics portfolio can be found at: http://www.perkinelmer.com/catalog/category/id/labchip%20systems

About Trinean

Trinean is a Belgium based instrumentation company, bringing micro-volume molecular spectroscopy to the next level by combining best in class analytical software with a highly standardized read-out platform.

Founded in 2006 as a spin-out of the Ghent University, Belgium and Imec Leuven, Belgium, the company commercializes two instruments, the Xpose for Touch & Go biomolecule quantification and the DropSense96®, analyzing up to 96 samples, using microfluidic chips for standardized sample analysis (DropPlates and Xpose Slides). The Trinean platform is complemented with a software toolbox (including DropControl, DropQuant, cDrop™) for improved data interpretation and lab-automation. For more information about Trinean, visit http://www.trinean.com

Further information:

Trinean N.V.

ir. Philippe Stas

Chief Executive Officer

Dulle Grietlaan 17/3

B-9050 Gent – Belgium

Tel.: +32-9-272.75.35

Fax.: +32-9-272.75.39

info@trinean.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->